The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site.

All material subject to strictly enforced copyright laws. © 2020 Euromoney, a part of the Euromoney Institutional Investor PLC.
Opinion

Environmental financing: Someone get the CEO of Bayer an aspirin

Greater consideration has to be given to financing conservation. That includes questioning the financing of firms that produce pesticides and herbicides.

ha_banner_column-780



It was Earth Day in April when we are reminded once again how we need to stop destroying the planet. A trip to the home and garden chain, Lowes, over that weekend underscored the need for reminders. In the garden section, at the front of the store, stood row upon row of Roundup – a glyphosate-based herbicide produced by Monsanto – that’s now Bayer’s headache since it bought Monsanto in 2018. 

People (and some city governments in the US) use Roundup to kill weeds; other living organisms that come into contact with it also die. It is the enemy of land conservation. And if that’s not enough for people to stop buying it, in March a jury in San Francisco awarded a man $80 million in damages after he claimed that Roundup caused his cancer – one of over 10,000 lawsuits filed against Monsanto

Monsanto could turn out to be a very bad buy for Bayer – a $66 billion bad buy. 

When the verdict was announced, the German firm saw its share price drop 40% – it has lost $34 billion of its market cap since August last year.




You have reached premium content. Please log in to continue reading.

Read beyond the headlines with Euromoney

For over 50 years, our readers have looked to Euromoney to stay informed about the issues that matter in the international banking and financial markets. Find out more about our different levels of access below.

SUBSCRIBE ONLINE TODAY

Unlimited access to Euromoney.com and Asiamoney.com

Expert comment, long reads and in-depth analysis interviews with senior finance professionals

Access the results of our market-leading annual surveys across core financial services

Access the results of our annual awards, including the world-renowned Awards for Excellence

Your print copy of Euromoney magazine delivered monthly

£73.75 per month

Billed Annually

FREE 7 DAY TRIAL

Unlimited access to Euromoney.com and Asiamoney.com, including our top stories, long reads, expert analysis, and the results of our annual surveys and awards

Sign up to any of our newsletters, curated by our editors

LOGIN NOW

Already a user?

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree